Miller Wealth Advisors’s AbbVie ABBV Stock Holding History

Miller Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.4K	Hold	240	–	–	0.03%	32
2026 Q1	$52.2K	Hold	240	–	–	0.02%	34
2025 Q4	$54.8K	Hold	240	–	–	0.02%	34
2025 Q3	$55.6K	Hold	240	–	–	0.02%	33
2025 Q2	$44.5K	Hold	240	–	–	0.02%	31
2025 Q1	$50.3K	Hold	240	–	–	0.03%	29
2024 Q4	$42.6K	Hold	240	–	–	0.02%	30
2024 Q3	$45.3K	Hold	240	–	–	0.02%	28
2024 Q2	$41.2K	Hold	240	–	–	0.02%	32
2024 Q1	$43.7K	Hold	240	–	–	0.03%	32
2023 Q4	$37.2K	Hold	240	–	–	0.02%	29
2023 Q3	$35.8K	Hold	240	–	–	0.02%	30
2023 Q2	$32.3K	Buy	240 +140	+140%	+$20.5K	0.02%	30
2023 Q1	$11K	Sell	100 -400	-80%	-$61.2K	0.05%	38
2022 Q4	$79K	Buy	500 +250	+100%	+$38.3K	0.05%	27
2022 Q3	$38K	Hold	250	–	–	0.03%	42
2022 Q2	$38K	Hold	250	–	–	0.03%	29
2022 Q1	$41K	Hold	250	–	–	0.03%	32
2021 Q4	$34K	Buy	+250	New	+$29.5K	0.02%	36

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Miller Wealth Advisors's ABBV Position: Q2 2026 in Review

Miller Wealth Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 240 shares worth $60.4K. The position accounts for 0.03% of the portfolio, ranked #32.

Miller Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $79K in Q4 2022. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Miller Wealth Advisors held 240 shares of AbbVie worth $60.4K as of Q2 2026.
Miller Wealth Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.03% of Miller Wealth Advisors's portfolio in Q2 2026, its #32 holding.
Miller Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Miller Wealth Advisors's AbbVie position peaked at $79K in Q4 2022.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.